MRK
Merck & Co Inc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Merck & Company Inc. (MRK) is a prominent global healthcare leader headquartered in Kenilworth, New Jersey, recognized for its innovative contributions to pharmaceuticals and vaccines aimed at improving health outcomes worldwide. Established in 1891, Merck boasts a diverse product portfolio that add...
$149.54
-2.33% ($3.56)
Volume
8.52M
52W High
$156.92
52W Low
$77.58
Market Cap
$315.57B
What to Watch This Quarter
Based on historical dataLast Quarter
-$0.13
Current Streak
7 Beats
Avg Surprise (4Q)
+18.55%
Next Earnings Report
Reports in 61 days
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q2 2026
Aug 4, 2026
1-Day:
+0.26%
Q1 2026
Apr 30, 2026
1-Day:
+2.73%
5-Day:
+3.64%
Q1 2026
Apr 23, 2026
1-Day:
-2.37%
5-Day:
-4.00%
Q4 2025
Feb 3, 2026
1-Day:
+2.15%
Revenue & Financial Performance
Revenue Whisper
$16.98B
TWN Proprietary Estimate
Last Quarter Revenue
$16.61B
+5.1% YoY
Gross Margin
73.5%
Net Margin: -8.0%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q2'26 | $16.61B | +5.1% | 73.5% | -2.6% | -$1.34B |
| Q1'26 | $16.29B | +4.3% | 81.9% | -11.6% | -$4.24B |
| Q4'25 | $16.32B | +4.5% | 70.5% | 37.7% | $2.96B |
| Q3'25 | $17.18B | +3.2% | 75.6% | 43.4% | $5.79B |
| Q2'25 | $15.80B | -1.9% | 75.7% | 40.3% | $4.43B |
| Q1'25 | $15.62B | -1.0% | 75.1% | 43.0% | $5.08B |
| Q4'24 | $15.62B | +6.8% | 75.5% | 27.8% | $3.74B |
| Q3'24 | $16.66B | +4.4% | 75.5% | 23.9% | $3.16B |
Company Information
Symbol
MRK
Company
Merck & Co Inc
Market Cap
$315.57B
Sector
HEALTHCARE
Next Earnings
Oct 29, 2026
Also Reporting Soon
Companies reporting earnings around the same time as MRK
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare MRK with competitors
Side-by-side earnings comparison